Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Alexion_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:focusesOn |
treatment of Wilson's disease
|
| gptkbp:founded |
2012
|
| gptkbp:founder |
Jonas Hansson
|
| gptkbp:headquarters_location |
gptkb:Stockholm
|
| https://www.w3.org/2000/01/rdf-schema#label |
Wilson Therapeutics
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:product |
WTX101
|
| gptkbp:stockExchange |
gptkb:Nasdaq_Stockholm
|
| gptkbp:stockSymbol |
WTX
|
| gptkbp:website |
https://www.wilsontherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:HealthCap
|
| gptkbp:bfsLayer |
8
|